AP2002002496A0 - Method and compositions for treating pulmonary diseases. - Google Patents

Method and compositions for treating pulmonary diseases.

Info

Publication number
AP2002002496A0
AP2002002496A0 APAP/P/2002/002496A AP2002002496A AP2002002496A0 AP 2002002496 A0 AP2002002496 A0 AP 2002002496A0 AP 2002002496 A AP2002002496 A AP 2002002496A AP 2002002496 A0 AP2002002496 A0 AP 2002002496A0
Authority
AP
ARIPO
Prior art keywords
compositions
pulmonary diseases
treating pulmonary
treating
diseases
Prior art date
Application number
APAP/P/2002/002496A
Other languages
English (en)
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AP2002002496A0 publication Critical patent/AP2002002496A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/2002/002496A 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases. AP2002002496A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
AP2002002496A0 true AP2002002496A0 (en) 2002-06-30

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002496A AP2002002496A0 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases.

Country Status (29)

Country Link
EP (1) EP1225866A4 (cs)
JP (1) JP2003513028A (cs)
KR (1) KR20020057988A (cs)
CN (1) CN1387404A (cs)
AP (1) AP2002002496A0 (cs)
AR (1) AR029189A1 (cs)
AU (1) AU1357501A (cs)
BG (1) BG106748A (cs)
BR (1) BR0015270A (cs)
CA (1) CA2388333A1 (cs)
CO (1) CO5261512A1 (cs)
CZ (1) CZ20021512A3 (cs)
DZ (1) DZ3225A1 (cs)
EA (1) EA200200518A1 (cs)
EC (1) ECSP003747A (cs)
HK (1) HK1049107A1 (cs)
HU (1) HUP0203152A3 (cs)
IL (1) IL149367A0 (cs)
MA (1) MA26841A1 (cs)
MX (1) MXPA02004350A (cs)
NO (1) NO20022057L (cs)
OA (1) OA12076A (cs)
PE (1) PE20011005A1 (cs)
PL (1) PL355261A1 (cs)
SK (1) SK7592002A3 (cs)
TR (1) TR200201211T2 (cs)
TW (1) TWI242431B (cs)
WO (1) WO2001032127A2 (cs)
ZA (1) ZA200203435B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160271A0 (en) * 2001-09-19 2004-07-25 Altana Pharma Ag Pharmaceutical compositions containing pde4-inhibitors and nsaid
CZ2004516A3 (cs) * 2001-10-31 2004-08-18 Merckápatentágmbh Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CN1767828A (zh) * 2003-03-31 2006-05-03 协和发酵工业株式会社 医药组合物
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
EP1810692A1 (en) * 2004-10-13 2007-07-25 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
RU2008119322A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Композиции ингибиторов фосфодиэстеразы iv типа
ES2702753T3 (es) 2010-01-05 2019-03-05 Microdose Therapeutx Inc Dispositivo de inhalación
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000139A1 (en) * 1993-06-18 1995-01-05 Smithkline Beecham Corporation Compounds
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
MXPA02004350A (es) 2002-11-07
JP2003513028A (ja) 2003-04-08
NO20022057D0 (no) 2002-04-30
WO2001032127A2 (en) 2001-05-10
HK1049107A1 (zh) 2003-05-02
ECSP003747A (es) 2002-05-23
CN1387404A (zh) 2002-12-25
CA2388333A1 (en) 2001-05-10
HUP0203152A3 (en) 2004-06-28
OA12076A (en) 2006-05-04
IL149367A0 (en) 2002-11-10
BR0015270A (pt) 2002-06-18
AU1357501A (en) 2001-05-14
SK7592002A3 (en) 2002-11-06
HUP0203152A2 (hu) 2003-01-28
EP1225866A4 (en) 2004-04-21
TR200201211T2 (tr) 2002-08-21
DZ3225A1 (fr) 2001-05-10
NO20022057L (no) 2002-06-27
KR20020057988A (ko) 2002-07-12
BG106748A (en) 2003-02-28
ZA200203435B (en) 2003-06-25
MA26841A1 (fr) 2004-12-20
EP1225866A2 (en) 2002-07-31
AR029189A1 (es) 2003-06-18
PE20011005A1 (es) 2001-09-28
PL355261A1 (en) 2004-04-05
EA200200518A1 (ru) 2002-10-31
CO5261512A1 (es) 2003-03-31
TWI242431B (en) 2005-11-01
CZ20021512A3 (cs) 2003-04-16
WO2001032127A3 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
MY126544A (en) Therapies for treating pulmonary diseases
MXPA02011311A (es) Composicion novedosa.
WO2003011274A3 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
EP1602370A3 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
LT2004060A (en) A composition for treating neurocerebrovascular disorders
WO2002088101A3 (en) Inhibitors of bace
WO1999005096A3 (en) Urokinase inhibitors
MXPA04000328A (es) Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer.
MXPA04002785A (es) Aminas sustituidas para tratamiento de enfermedad de alzheimer.
TNSN04165A1 (en) Substituted hydroxyethylamines
MXPA04000338A (es) Diamindioles para tratamiento de enfermedad de alzheimer.
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
MXPA03011521A (es) Aminadioles para tratamiento de enfermedad de alzheimer.
AP2002002496A0 (en) Method and compositions for treating pulmonary diseases.
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
WO2004028548A3 (en) Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents
AU4080097A (en) Piperazino derivatives as neurokinin antagonists
PL323235A1 (en) Derivatives of piperazine as neurokinin antagonists
BG105953A (bg) Метод за лечение на хронична обструктивна белодробна болест
SE9900834D0 (sv) Novel combination
HK1051319A1 (zh) 治疗感染疾病的方法和组合物
MXPA04000337A (es) Amindioles para tratamiento de enfermedad de alzheimer.